Regulation: First stem cell therapy reaches EU market – European Biotechnology News
European Biotechnology News |
Regulation: First stem cell therapy reaches EU market
European Biotechnology News Holoclar is the first treatment for the rare eye disease limbal stem cell deficiency and is based on autologous stem cells. Seven years ago, Holoclar had been designated an orphan medicinal product. The European Medicines Agency (EMA) recommended … |
